Postmenopausal Bleeding: Urgent Evaluation Required

Postmenopausal Bleeding (PMB) Is Never Normal

Defined as any vaginal bleeding ≥12 months after final menstrual period. Requires prompt investigation to exclude endometrial cancer (risk ~10%, increases with age).

Common Causes (Benign → Malignant)

  • Endometrial Atrophy: Thin, fragile lining (low estrogen) – most common cause.
  • Endometrial Polyps: Localized overgrowths; often cause spotting.
  • Hormone Therapy: Unopposed estrogen, sequential HT, tamoxifen.
  • Endometrial Hyperplasia: Unopposed estrogen → architectural crowding ± atypia → cancer precursor.
  • Endometrial Cancer (EC): Most common gynecologic cancer. Peak 60–70y. Risk: obesity, nulliparity, late menopause, PCOS, Lynch syndrome, tamoxifen.
  • Cervical/Vaginal Atrophy, Infection, Trauma.
  • Anticoagulants.

Diagnostic Workup (ACOG/ESGO Guidelines)

  1. History & Exam: Bleeding pattern, risk factors, medications, speculum/bimanual.
  2. Transvaginal Ultrasound (TVUS): Measure endometrial thickness (EMT).
    • EMT ≤4 mm: NPV >99% for EC (if adequate visualization). Can avoid biopsy if low risk.
    • EMT >4 mm or inadequate view: Proceed to tissue sampling.
  3. Tissue Sampling:
    • Endometrial biopsy (office Pipelle) – first-line.
    • Hysteroscopy + D&C – if biopsy insufficient, focal lesion suspected, or AUB-H.
  4. Cervical Cancer Screening: Co-test if due.

Management by Finding

  • Atrophy: Vaginal estrogen (low dose), reassurance.
  • Polyps: Hysteroscopic polypectomy.
  • Hyperplasia without atypia: Progestin therapy (IUD, oral) + surveillance.
  • Hyperplasia with atypia / Cancer: Gynecologic oncology referral – hysterectomy ± staging.

Key Message

Do not wait. Do not assume it's "just hormones." Early EC is highly curable (5-yr survival >90%). Delay costs lives.

Blood Disorders - Related Articles